Ocean Biomedical, Inc. (OCEA)
OTCMKTS · Delayed Price · Currency is USD
0.0008
0.00 (0.00%)
At close: Sep 30, 2026
Ocean Biomedical Market Cap
Ocean Biomedical has a market cap or net worth of $185.89 thousand as of September 30, 2026. Its market cap has decreased by -88.57% in one year.
Market Cap
185.89K
Enterprise Value
15.54M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since November 8, 2021, Ocean Biomedical's market cap has decreased from 105.68M to 185.89K, a decrease of -99.82%. That is a compound annual growth rate of -72.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 185.89K | 60.00% |
| Dec 31, 2025 | 116.18K | -99.40% |
| Dec 31, 2024 | 19.28M | -14.29% |
| Dec 29, 2023 | 22.50M | -79.59% |
| Dec 30, 2022 | 110.24M | 4.10% |
| Dec 31, 2021 | 105.89M | 0.20% |
| Nov 8, 2021 | 105.68M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Actavia Life Sciences | 385.91K |
| Lyra Therapeutics | 354.98K |
| MetaStat | 319.73K |
| Burzynski Research Institute | 256.32K |
| Ampio Pharmaceuticals | 207.88K |
| Virpax Pharmaceuticals | 192.59K |
| CNBX Pharmaceuticals | 192.58K |
| Regen BioPharma | 167.53K |